Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. In addition to these issues, further barriers to drug access remain in the UK and US.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. In addition to these issues, further barriers to drug access remain in the UK and US.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98

Putting Patients First Blog

MARCH 29, 2023

We encourage Congress to work with the FDA to analyze the impacts of these factors and consider ways to support this progress in future pandemic responses and apply the lessons to other areas of drug development including emerging new needs that have arisen due to COVID-19 infections, including supporting individuals with Long COVID.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Vaccines Documentation Hospitals 40